Auxly Cannabis Group Inc.

TSX:XLY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.53 +0.00%

+$0.00 today

Market cap
$364.42M
Beta
1.16
P/E (TTM)
7.3
EPS (TTM)
$0.02
52W Low $0.08High $0.19

Volume 0.13M

Average 0.71M

XLY.TO Long-term Debt

Borrowings due after more than one year.

Auxly Cannabis Group Inc.TSX: XLY.TO

Long-term Debt · Q1 FY2026 · quarter ended Mar 2026

Long-term debt rises 1203.3% from a year ago

Long-term debt stood at CA$38.89M at the end of Q1 FY2026, up 1203.3% from a year earlier and down 3.2% from the prior quarter. Over 3 fiscal years it compounded at -30.5% a year.

Context

  • Long-term debt amounted to 13.9% of total assets at the end of Q1 FY2026, up 12.8 pp from a year earlier.
  • Long-term debt increased in 1 of the last 3 fiscal years.

What to watch

Whether long-term debt keeps rising in the next quarterly balance sheet after a +1203.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$38.89M-3.2% QoQ
Last fiscal yearDec 2025
CA$40.16M+1201.3% YoY
Year agoMar 2025
CA$2.98M+1203.3% since
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1203.3%——
1 year+1201.3%——
3-year CAGR-30.5%——
5-year CAGR——
10-year CAGR——

Long-term Debt history

CAD · from the balance sheet

Latest · FY2025
40.16M CAD
Year-over-year change
+1201.3%
4-year CAGR
-28.2%

Long-term Debt vs competitors

How XLY.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so long-term debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +1203.3% is the highest of 3, against a peer median of -22.0%.
  • Long-term debt amounts to 13.9% of total assets for XLY.TO, versus a peer median of 14.0%.
XLY.TO Competitors
Long-term Debt for XLY.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$38.89M CAD+1203.3%-30.5%13.9%
HLS.TOHLS Therapeutics Inc.Mar 2026$38.82M USD-32.6%-18.9%29.6%
CRRX.TOCareRx CorporationMar 2026CA$34.79M CAD-11.4%-28.7%14.0%
CRDL.TOCardiol Therapeutics Inc.Mar 2026CA$0 CAD——0.0%
Peer median (excluding XLY.TO) —-22.0%-23.8%14.0%

Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents14.75M14.64M15.61M18.36M32.53M
Short-term Investments140K143K143K143K142K
Net Receivables31.21M17.53M16.73M22.57M22.38M
Inventory58.94M54.46M31.43M34M42.34M
Other Current Assets2.99M557K1.59M557K472K
Total Current Assets119.97M89.9M65.99M76.61M99.24M
Property, Plant & Equipment (Net)226.48M195.27M158.96M150.81M143.64M
Goodwill24.29M0000
Intangible Assets74.2M45.47M29.88M29.76M28.21M
Long-term Investments3.9M1.09M1.1M594K261K
Tax Assets00000
Other Non-current Assets1.58M87K5.98M3.76M290K
Total Non-current Assets330.45M241.92M195.92M184.92M172.4M
Total Assets450.42M331.82M261.9M261.53M271.64M
Account Payables30.57M33.05M41.3M44.9M35.8M
Short-term Debt17.45M54.67M61.35M51.6M6.12M
Tax Payables00000
Deferred Revenue295K000351K
Other Current Liabilities1.3M500K256K3.75M0
Total Current Liabilities53.65M92.69M106.97M123.29M45.13M
Long-term Debt151.36M119.8M81.38M3.09M40.16M
Deferred Tax Liabilities17.54M11.36M8.13M8.13M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.5M7.42M1.89M8.12M0
Total Non-current Liabilities188.66M153.45M103.89M22.58M48.93M
Total Liabilities242.31M246.13M210.86M145.87M94.06M
Common Stock436.51M444.76M446.56M542.63M549.56M
Retained Earnings(308.47M)(438.76M)(483.27M)(499.62M)(457.77M)
Accumulated OCI84.48M84.41M48.26M(30.2M)42.86M
Other Stockholders Equity00063.34M0
Minority Interest(4.41M)(4.72M)000
Total Equity208.11M85.69M51.05M115.66M177.58M
Total Debt190.1M193.59M159.05M68.48M57.65M
Net Debt175.35M178.96M143.44M50.12M25.12M

Auxly Cannabis Group Inc.

TSX:XLY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.